Found 85 clinical trials
v6.11_prescreener_study(please don't touch)
Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments.This study aims …
- 0 views
- 19 Feb, 2024
- 2 locations
Test RTE
Study Overview Study Details Eligibility Trial Primary Objective:To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)Secondary Objectives:To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivationTo continue to …
- 0 views
- 19 Feb, 2024
Assessment of the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
- 0 views
- 19 Feb, 2024
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.
- 32 views
- 20 Sep, 2024
- 127 locations
Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)
Primary Objectives:To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.To evaluate the time-course of AD and selected atopic comorbidities.
- 0 views
- 23 May, 2025
- 1 location